- Investing Ideas
- Japanese Pharmaceuticals & Biotech Bank Account Beaters
Japanese Pharmaceuticals & Biotech Bank Account Beaters
Results
6
Companies that are expected to sustainably pay a dividend that beats your savings account (over 3%).
6 companies
Takeda Pharmaceutical
Market Cap: JP¥8.4t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,269.00
7D
-9.9%
1Y
24.3%
Daiichi Sankyo Company
Market Cap: JP¥4.7t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,585.00
7D
-10.4%
1Y
-29.3%
Astellas Pharma
Market Cap: JP¥3.9t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,159.00
7D
-5.9%
1Y
35.5%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,301.00
7D
-7.6%
1Y
34.6%
Tsumura
Market Cap: JP¥276.9b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,714.00
7D
-8.2%
1Y
4.5%
Nippon Shinyaku
Market Cap: JP¥234.1b
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.
4516
JP¥3,473.00
7D
-2.2%
1Y
4.8%